Many cancer cells have ‘eat me’ signal: Study
December 23rd, 2010 - 5:49 pm ICT by ANIWashington, Dec 23 (ANI): A new study has found that many cancer cells carry the seeds of their own destruction - a protein on the cell surface that signals circulating immune cells to engulf and digest them.
On cancer cells, this “eat me” signal is counteracted by a separate “don’t eat me” signal that was described in an earlier study. The two discoveries may lead to better cancer therapies, and also solve a mystery about why a previously reported cancer therapy is not more toxic.
Researchers at the Stanford University School of Medicine discovered that many forms of cancer display the protein calreticulin, or CRT, which invites immune cells called macrophages to engulf and destroy them.
The reason most cancer cells are not destroyed by macrophages is that they also display another molecule, a “don’t eat me” signal, called CD47, which counteracts the CRT signal.
“This research demonstrates that the reason that blocking the CD47 ‘don’t eat me’ signal works to kill cancer is that leukemias, lymphomas and many solid tumors also display a calreticulin ‘eat me’ signal,” said Irving Weissman, director of the Stanford Institute for Stem Cell Biology and Regenerative Medicine.
“The research also shows that most normal cell populations don’t display calreticulin and are therefore not depleted when we expose them to a blocking anti-CD47 antibody,” Weissman said.
The researchers also found that the most aggressive cancers were the ones making the most CRT.
The study has been published Dec. 22 in Science Translational Medicine. (ANI)
- Novel immune therapy for pancreatic cancer discovered - Mar 25, 2011
- Bladder cancer stem cell discovered - Aug 04, 2009
- How Alzheimer's plaques lead to loss of nitric oxide in brain - Jan 11, 2011
- Macrophage protein plays major role in inflammation - Nov 03, 2010
- Stem cell revolution can defeat Alzheimer's - Jun 05, 2011
- How breast cancer cells dodge immune system and survive - Feb 02, 2011
- Unexpected find may lead to novel ways to stop HIV - Jan 24, 2011
- Melanoma-initiating cell identified - Jul 01, 2010
- How reovirus kills cancer cells - Feb 21, 2011
- Study on zebrafish paves way for new cancer treatment - Dec 15, 2010
- Sun-triggered protein 'makes skin cancer worse' - Feb 04, 2011
- Two-sided immune cell could be harnessed to shrink tumours: Study - Oct 29, 2010
- Indian origin scientist's gene therapy shows promise in slowing AMD - Apr 30, 2011
- India-Cuba joint discovery in biomedical sciences wins award - Jul 19, 2011
- Cell that suppresses immune system discovered - Oct 05, 2010
Tags: antibody, calreticulin, cancer cells, cancer therapies, cancer therapy, cancers, cell populations, cell surface, crt, discoveries, immune cells, irving weissman, macrophages, molecule, school of medicine, stanford institute, stanford university school, stanford university school of medicine, stem cell biology, translational medicine